Today marked the 4th day of new lows expanding. A healthy market typically has few new 52 week lows. Today we had 55 new highs and 177 new lows on the Nasdaq. This is subtle distribution under the surface exposing the weakness in underlying stocks. This condition needs to flip

The market leaders of this uptrend is under pressure. Often when the market is concentrated in a small group of leaders, the "generals" are the last to come under selling pressure despite the fundamentals. This is our interpretation of what is happening today. Market corrections

Maximum Defense. We moved to primarily cash today as a result of the Nasdaq's weakening condition and the widespread poor breadth in the overall market. Today was day 4 off the top in the indexes. With the 2% decline within 4-7 days off the top, this signal alerted us to

Palantir $Pltr reports a pristine quarter. While the company added arguably the best 4 quarters of any software company in history, the valuation metrics provided a sell on the news event. That translated to a market selloff. While the company's valuation seemingly has put a

Great report by SPX Technologies $Spxc a Charlotte, NC stalwart.

We are initiating an initial position in Cameco here. https://t.co/3vKLF2qGBu

Cloudflare breaking out on earnings. We are adding a half position in $Net https://t.co/GN0zv8xSq9

Cameco $Ccj planting their flag in the Nuclear space with the US Government deal with Westinghouse nuclear reactors.

$Nvda establishes a relationship with Nokia $Nok. This perhaps is a life line to a lagging legacy company much like $Intc. Regardless, the technical action is pristine. A breakout above $9 would signify a 8 year breakout. Today the stock is providing a 10%price/300% volume

Snowflake $Snow quickly moving up on our screens. A partnership a few days ago with $Pltr should enhance their visibility and results in the future.

2 Biotech Leaders we are watching include Alnylam Pharmaceuticals $Alny and Argenx $Argx. Earnings risk next week, however. The SPDR S&P Biotech index $Xbi may be a favored way to play the increased interest and leadership in the biotech space moving forward.

The market's positive seasonality is kicking in. While extremely choppy, we are expecting a strong end to the year. It could be a barn burner. The most difficult element to conquer is staying on the bucking bronco which has been difficult to say the least.

Inflation results powering market ahead. Raising exposure.

Adding SoFi Technologies $Sofi as it approaches its $30.30 breakout. $Sofi has produced 4 consecutive quarters of triple digit accelerating numbers. With the market outlook quickly improving it represents a balance of strong financials and bullish sentiment as the Fed lowers

Yesterday by definition the Nasdaq experienced a distribution day as volume swelled on the down day; However, keep in mind out of the 14 Billion shares that were traded, 2 Billion each were from 2 speculative names: $Yyai and $Bynd. I would not touch either with a 10 ft. pole!

We are taking an oversized position in $Mags here. It is on the cusp of breaking into all time high territory at $65.73. The $Mags etf represents some of the leading technology stocks in the market today: $Amzn, $Aapl, $Googl, $Meta, $Msft, $Nvda, and $Tsla. Most of these report

Extremely choppy market. We got stopped out of some positions yesterday that we are putting back on such as $Bwxt, $Tsla, $Mags. Additionally we are initiating the most powerful stocks on our buy list which include $Vrt, $Crwd, $Anet, and $Crdo. Also watching $Glxy, $Wulf and

Terrific massive upside results in Galaxy $Glxy in their reported quarter today. Impressive.

We are initiating a full position in $Mags which reflects the Magnificient 7 stocks.